Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Virtual reality relaxation to reduce pain during elective egg retrieval

Official title: The Effectiveness of Virtual Reality for Pain Reduction in Women Undergoing Elective Oocyte Cryopreservation: A Randomized Controlled Trial

Run by Hadassah Medical Organization · NCT07484815 · Data updated 2026-11-12

This tests whether about 20 minutes of relaxing VR nature scenes before elective egg retrieval can lower pain for women having egg freezing.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment100 (estimated)
SponsorHadassah Medical Organization
Academic / other
Locations1 site (Jerusalem)
StatusRecruiting
StartedNovember 5, 2024
Main results expectedAugust 2026
Study endsDecember 2026
Registry record updatedMarch 20, 2026
Trial IDNCT07484815 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–45 undergoing elective oocyte cryopreservation who can safely use a VR headset and are not taking excluded medications or have contraindicated conditions are ideal candidates.

Probably not a fit

Patients with seizure history, flashing-light or motion sensitivity, migraines, vertigo, or recent use of pain-relief, anti-anxiety, or antidepressant medications may be excluded or unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled trial enrolls women aged 18–45 undergoing elective oocyte cryopreservation and randomly assigns them to routine care alone or routine care plus a roughly 20-minute VR-based relaxation session before retrieval. Pain is measured using validated scales including the visual analog scale before and after the procedure, with secondary outcomes of pain sensitivity, analgesic consumption, and physiological parameters. Participants with contraindications to VR (for example, history of seizures, severe motion sensitivity, migraines, or current use of certain psychoactive medications) are excluded. The VR intervention is delivered via a headset in the clinic waiting area immediately prior to the oocyte retrieval.

Why it matters

Potential benefit: If effective, the VR intervention could reduce procedure-related pain and the need for additional pain medication, improving comfort during egg freezing.

How similar studies have gone: VR-based relaxation has reduced pain and anxiety in various procedural settings, although evidence specifically for oocyte retrieval is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women undergoing elective oocyte retrieval for fertility preservation.
* Age 18-45 years.
* Ability to provide informed consent.

Exclusion Criteria:

* Use of pain relief, anti-anxiety, or antidepressant medications prior to the intervention.
* Any condition for which VR use is not recommended, including:

  * History of seizures
  * Sensitivity to flashing light or motion
  * Migraine headaches
  * Predisposition to nausea or dizziness (e.g., vertigo)
* Any injury to the eyes, face, or neck limiting use of the VR device, including blindness.

Where it's running

  • Hadassah Medical Organization
    Jerusalem, Israel
    Recruiting

Study contacts

  • Principal investigator: Anat Hershko-Klement, MD — Hadassah Medical Center, Mount Scopus Campus, Jerusalem, Israel
  • Study coordinator: Adar Hamrani, MD
  • Email: adarha@hadassah.org.il
  • Phone: +972-54-5560848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.